BioCryst Pharmaceuticals, Inc. (BCRX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 5.26 |
| Open | 5.18 |
| Bid | 5.08 x 1200 |
| Ask | 5.12 x 600 |
| Day's Range | 5.05 - 5.42 |
| 52 Week Range | 4.03 - 8.96 |
| Volume | |
| Avg. Volume | 3,441,214 |
| Market Cap | 1.052B |
| Beta (5Y Monthly) | 1.93 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Insider Monkey
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q1 2024 Earnings Call Transcript
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q1 2024 Earnings Call Transcript May 6, 2024 BioCryst Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.31 EPS, expectations were $-0.23. BCRX isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, and welcome […]
- Simply Wall St.
BioCryst Pharmaceuticals First Quarter 2024 Earnings: Beats Expectations
BioCryst Pharmaceuticals ( NASDAQ:BCRX ) First Quarter 2024 Results Key Financial Results Revenue: US$92.8m (up 35...
- GuruFocus.com
BioCryst Pharmaceuticals Inc (BCRX) Q1 2024 Earnings Call Transcript Highlights: Key Financial ...
Discover how BioCryst Pharmaceuticals Inc (BCRX) navigated the first quarter of 2024, with detailed financial results and strategic updates.
© 2024 Yahoo. All rights reserved.